Records View

Clinical study of high added value food material for periodontal disease prevention and improvement

Status Approved

  • First Submitted Date

    2019/11/11

  • Registered Date

    2019/11/19

  • Last Updated Date

    2019/11/11

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0004448
    Unique Protocol ID 2-2016-0044
    Public/Brief Title Clinical study of high added value food material for periodontal disease prevention and improvement
    Scientific Title Clinical study of high added value food material for periodontal disease prevention and improvement
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol
    Registered at Other Registry No
    Healthcare Benefit Approval Status Not applicable
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number 2-2016-0044
    Approval Date 2017-01-26
    Institutional Review Board Name Institutional Review Board of Yonsei University Dental Hospital
    Institutional Review Board Address 50-1, Yonsei-ro, Seodaemun-gu, Seoul
    Institutional Review Board Telephone 02-2228-8613
    Data Monitoring Committee No
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Seong-Ho Choi
    Title Prof
    Telephone +82-2-2228-8820
    Affiliation Yonsei University Health System, Dental Hospital
    Address Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul
    Contact Person for Public Queries
    Name Inpyo Hong
    Title Resident
    Telephone +82-2-2228-8820
    Affiliation Yonsei University Health System, Dental Hospital
    Address Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul
    Contact Person for Updating Information
    Name Inpyo Hong
    Title Resident
    Telephone +82-2-2228-8820
    Affiliation Yonsei University Health System, Dental Hospital
    Address Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Completed
    Date of First Enrollment 2017-06-14 Actual
    Target Number of Participant 100
    Primary Completion Date 2018-11-30 , Actual
    Study Completion Date 2018-11-30 , Actual
    Recruitment Status by Participating Study Site 1
    Name of Study Yonsei University Health System, Dental Hospital
    Recruitment Status Completed
    Date of First Enrollment 2017-06-14 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Ministry of Agriculture, Food and Rural Affairs
    Organization Type Government
    Project ID
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Yonsei University Health System, Dental Hospital
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    Purpose: Through nationally assigned projects about the development of high value-added food for the prevention and treatment of periodontal disease, the extraction of Ligularia stenocephala and wheat sprout (ELW) was introduced. ELW showed its efficacy in vivo and in vitro. The aim of this clinical study is to determine the efficacy of ELW in prevention and treatment of periodontitis in humans.
    
    Backgrounds:
    - Matrix metalloproteinase (MMP) is induced by inflammatory cytokines and plays a significant role in development of periodontal disease. Since its significant role in periodontal disease, various substances have been developed for inhibition of MMPs. Tetracycline is one of the MMP inhibiting antibiotics, but it has limitations in general application to patients.
    - There is an over-the-counter medicine for periodontal disease based on unsaponifiable material from saponification of corn. It consists of beta-sitosterol, squalene, carotene tocopherol and more. Beta-sitosterol which is pro-vitamin D is known to be effective for periodontal health, however, there is no sufficient evidence for support. There is controversial that this kind of medicines are just nutrition without any specific efficacy for periodontal health.
    - Also, there is another type of over-the counter medicine for periodontal disease, which consists of vitamin E, C and inhibiting materials for inflammation and bleeding. This kind of medicines has limitation that it cannot deal with fundamental causes of periodontal disease. Thus, taking this kind of medicine cannot accomplish periodontal health.
    - Most of medicines for periodontal disease are composed of ascorbic acid, herbal extracts or antibiotics like doxycycline and chlorhexidine. They mainly work as anti-inflammatory and anti-microbial. Only a few studies evaluated specific efficacy to periodontal disease
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
     Supportive Care
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Double
    Blinded Subject Subject, Investigator
    Allocation RCT
    Intervention Type Dietary Supplement  
    Intervention Description
    - Test group: Extraction of Ligularia stenocephala and wheat sprout (ELW) 300mg capsule (extracted with 50% alcohol), 1 capsule for daily oral intake for 4 weeks
    _ Control group: Placebo dextrin 300mg capsule with same shape and color with ELW. 1 capsule for daily oral intake for 4 weeks
    Subjects were randomly assigned to test and control group. There was no intervention to subjects without daily oral intake of assigned capsule.
    Number of Arms 2
    Arm 1

    Arm Label

    Daily oral intake of a 300mg capsule of extraction of Ligularia stenocephala and wheat sprout (ELW) (extracted with 50% alcohol)

    Target Number of Participant

    50

    Arm Type

    Experimental

    Arm Description

    - Test group: Extraction of Ligularia stenocephala and wheat sprout (ELW) 300mg capsule (extracted with 50% alcohol), 1 capsule for daily oral intake for 4 weeks
    Arm 2

    Arm Label

    Daily oral intake of placebo dextrin 300mg capsule with same shape and color with ELW

    Target Number of Participant

    50

    Arm Type

    Placebo comparator

    Arm Description

    _ Control group: Placebo dextrin 300mg capsule with same shape and color with ELW. 1 capsule for daily oral intake for 4 weeks
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (K00-K93)Diseases of the digestive system 
       (K05.6)Periodontal disease, unspecified 

    Subjects who are diagnosed as gingivitis or chronic generalized incipient to moderate periodontitis.
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    18Year~80Year

    Description

    1) Male or female whose age is in 18~80 years old
    2) Subjects who have more than 18 natural teeth
    3) Subjects who have sites with probing depth more than 3mm
    4) Subjects who have at least two teeth with bleeding on probing in a sextant
    5) Subjects who are diagnosed as gingivitis or chronic generalized incipient to moderate periodontitis
    Exclusion Criteria
    1) Subjects who did not sign on a written consent form.
    2) Subjects who are pregnant or lactating
    3) Subjects who have uncontrolled systemic diseases like severe hypertension and diabetes
    4) Subjects who did not enroll in other clinical studies in recent 3 months
    5) Subjects who are intaking antiplatelet or anticoagulant or who have hemorrhagic disease
    6) Subjects who had cancer in past 5 years.
    7) Subjects who had antibiotic therapy in a recent month
    8) Subjects who had periodontal treatment in recent six month, except scaling
    9) Subjects who have pathologic appearance (e.g: leukoplakia, lichen planus)
    10) Subjects who are decide not to be appropriate in clinician's decision
    11) Subjects who had allergy in ingredients for medication
    12) Subjects who smokes more than 10 cigarrettes / day
    Healthy Volunteers Yes
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome /Safety/Efficacy
    Primary Outcome(s) 1
    Outcome
    Bleeding on probing, Clinical attachment loss
    Timepoint
    Every visits.
    Secondary Outcome(s) 1
    Outcome
    Levels of biomarkers in saliva and gingival crevicular fluid
    Timepoint
    First visit and last visit
    Secondary Outcome(s) 2
    Outcome
    Blood test data
    Timepoint
    First visit and last visit
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered No
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement No
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동